secwatch.observer — SEC 8-K summary
======================================

Issuer:     Runway Growth Finance Corp. (RWAY)
CIK:        0001653384
Form:       8-K
Filed at:   2026-10-13T12:30:14+00:00
Accession:  0001193125-26-419756
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Runway Growth Q3 2026: $139.4M portfolio repayments, $8.5M new fundings
-----------------------------------------------------------------------

- Liquidity events totaled $139.4M: Extensiv (3PL Central) $72.3M, Route 92 Medical $35.0M, Onward Medical $17.1M, Federal Hearings & Appeals Services $6.3M, plus $8.7M amortization.
- Funded about $8.5M of follow-on investments in four existing portfolio companies, including $2.9M to three existing portfolio companies.
- Restructured ~$28.9M of unfunded Marley Spoon SE commitments into a €8.1M bridge loan ($5.6M funded); Marley Spoon cutting 21% of its workforce.
- Portfolio as of Sept 30, 2026: 52 debt investments across 42 companies and 102 equity investments in 66 companies; 31 hold both.
- Co-CEOs David Spreng and Michael Rovner say the share price does not reflect portfolio fundamentals; cite share repurchases and selective originations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1653384/000119312526419756/0001193125-26-419756-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1653384/000119312526419756/rway-20261013.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-419756

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer